D
Revolution Medicines, Inc. RVMD
$39.12 $0.090.23%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024
Revenue -- --
Total Other Revenue -- --
Total Revenue -- --
Cost of Revenue 23.95% 1,087.88%
Gross Profit -23.95% -1,087.88%
SG&A Expenses 17.75% 10.36%
Depreciation & Amortization -- --
Other Operating Expenses -- --
Total Operating Expenses 23.10% 12.17%
Operating Income -23.10% -12.17%
Income Before Tax -24.98% -17.30%
Income Tax Expenses -- --
Earnings from Continuing Operations -24.49% -17.30%
Earnings from Discontinued Operations -- --
Extraordinary Item & Accounting Change -- --
Minority Interest in Earnings -- --
Net Income -24.49% -17.30%
EBIT -23.10% -12.17%
EBITDA -23.27% -12.37%
EPS Basic -19.55% -16.10%
Normalized Basic EPS -20.00% -16.12%
EPS Diluted -19.55% -16.10%
Normalized Diluted EPS -20.00% -16.12%
Average Basic Shares Outstanding 4.14% 1.03%
Average Diluted Shares Outstanding 4.14% 1.03%
Dividend Per Share -- --
Payout Ratio -- --
Weiss Ratings